24 results
6-K
EX-10.1
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Report of Foreign Private Issuer
4:02pm
or, to the Company’s knowledge, threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge
424B5
ENLV
Enlivex Therapeutics Ltd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
and that is still valid; or
at the time the action was brought in the foreign court, a lawsuit in the same matter and between the same parties was pending
F-3
ENLV
Enlivex Therapeutics Ltd
29 Apr 22
Shelf registration (foreign)
8:14am
in the same matter between the same parties and that is still valid; or
at the time the action was brought in the foreign court, a lawsuit in the same matter
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
19 Nov 21
Condensed Consolidated Financial Statements
4:30pm
Israeli plaintiff filed a request in the Israeli court of Tel Aviv to approve an Israeli class action lawsuit against the Company. The claim alleges
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
6 Aug 21
Condensed Consolidated Financial Statements
4:31pm
to approve his lawsuit as an Israeli class action lawsuit against the Company. The claim alleges that the Company did not make various documents filed
6-K
EX-1.1
tf9lowgs15d 70rn
12 Feb 21
Enlivex Announces Closing of Previously Announced Bought Deal Offering of Approximately $46.0 Million Ordinary Shares
5:17pm
424B5
oyctu3b
10 Feb 21
Prospectus supplement for primary offering
5:22pm
424B5
n009pgl7j
9 Feb 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-10.1
qgg8 3qnsrl
22 Oct 20
Report of Foreign Private Issuer
8:47am
424B5
b0cle5j0drh
22 Oct 20
Prospectus supplement for primary offering
8:45am
6-K
EX-1.1
9sgg4z
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
958iwekt7jdxu53ldak
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
2lmh472
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
1noro
26 Feb 20
Prospectus supplement for primary offering
8:23am
424B5
za4j2e1we91hz0
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
3ggdp32uqwmofc4pzdg3
10 Jul 19
Prospectus supplement
8:18am
F-3
hr73o2 n0oggfqfzw1
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
zn3i qlpz1ytbs
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.1
xtjf6
19 Feb 19
Asset Purchase Agreement
4:57pm